. There was no difference in the number of patients that answered they will repeat the prostate exam next year (96% vs. 90%, p = 0.211) 
MATERIALS AND METHODS

Patient Selection
During a prostate cancer screening program at our Institution, 200 patients completed a questionnaire regarding pain and discomfort during DRE and its potential impact on future examination.
In the first part of the study, 100 patients voluntarily undergoing prostate cancer screening were included. Illiterate patients, those who did not consent with the study, and patients with clinical or laboratory evidence of urinary tract infection or prostatitis were excluded.
In a second part, 100 patients were randomly divided in two subgroups to analyze if emptying the bladder -or not -immediately before DRE reduces patient discomfort. Fifty patients were asked to urinate immediately before examination (intervention group) and 50 patients underwent DRE without urinating (control group). Patients were matched by age (between 50 and 59 years), level of education (complete elementary school or higher), AUA prostate symptom score (less than or equal to 7), and prostate specific antigen (PSA) value (below 4.0 ng/dL). Patients with current history of pain or bleeding with bowel movements, prior history of anal surgery, and those with DRE suspicious for cancer were excluded from this part of the study. Randomization was stratified according to the day of the week DRE was performed. Patients were asked to urinate before examination if they were examined on Mondays, Wednesdays, and Fridays. Patients undergoing DRE on Tuesdays and Thursdays underwent examination without urinating. DRE was performed in all patients by the same investigator (FRR) in the modified lithotomy position with the use of topical lidocaine 2% gel.
Questionnaire
Immediately after examination, each patient responded a self-administered anonymous questionnaire containing 5 questions. The first three questions regarded patient discomfort related to pain, urinary urgency, and bowel urgency. Impact of discomfort on potential future screening compliance was evaluated with questions 4 and 5 (Table I) .
Statistical analyses
To evaluate discomfort improvement with micturition immediately before DRE, discomfort grade was expressed as categorical variables (absent/mild
INTRODUCTION
Prostate cancer is the most common form of noncutaneous cancer in men and the second leading cause of male cancer mortality. In the United States, it is estimated that 218,890 new cases and 27,050 deaths from prostate cancer will occur in 2007 (1). It is widely recognized that digital rectal examination (DRE) is an important tool that should be routinely performed when screening for prostate cancer. Compared to the large amount of prostate cancer screening literature, very little has been written about patient pain or discomfort during DRE. Although several patient information guides report DRE causes no pain (2-4) or a slight discomfort (5,6) it has been reported physicians tend to give lower ratings of patients' pain than do the patients themselves (7). To our knowledge there are no studies specifically addressing patients' perception of pain or discomfort during DRE.
Anticipated pain or discomfort is an important barrier to prostate cancer screening (8), and it may impair future examination compliance (9-11). To help in patient information and counseling for prostate cancer screening we performed a study to evaluate patients' perception of pain and discomfort during DRE. We also evaluated the impact of discomfort on potential future screening compliance, and if emptying vs. moderate/severe/unbearable) in the two subgroups of the study. Impact of discomfort on potential future screening compliance was also expressed as categorical variables (yes vs. no).
Categorical data was analyzed using Fisher or Chi Square tests. Continuous data were evaluated using the Mann-Whitney U test. Statistical significance was considered for values p < 0.05.
RESULTS
For the first part of the study median age was 50 years (range 40 -66). Seventeen (17%) patients had incomplete elementary school education and 73 (73%) patients had a complete elementary school or higher education. Median AUA prostate symptom score was 3 ± 4 (range 0 to 19). Median PSA level was 0.79 ± 1.02 ng/dL (range 0.17 to 8.55). Discomfort grade related to pain, urinary urgency and bowel urgency is summarized in Table I . Seventy-three (73%) patients reported moderate, severe or unbearable discomfort for at least one domain during DRE: 61% complained of pain; 22% of urinary urgency; and 22% of bowel urgency. Ninety-four (94%) patients answered they will repeat the prostate exam next year and 95 (95%) would encourage a friend that needs the prostate exam to do it.
For the second part of the study median age was 52 years (range 50 -59) for the group of patients that was asked to urinate immediately before DRE (intervention group) and 52 years (range 50 -59) for the control group (p = 0.684). Median AUA prostate symptom score was 2 ± 2 (range 0 to 7) in intervention group and 2 ± 2 (range 0 to 7) in the control group (p = 0.975). Median PSA level was 0.74 ± 0.45 ng/dL (range 0.03 to 1.98) and 0.77 ± 0.75 (range 0.17 to 3.71) in intervention and control groups respectively (p = 0.352).
Emptying the bladder immediately before examination did not reduce the incidence of moderate, severe or unbearable pain (58% vs. 50%, p = 0.115), urinary urgency (22% vs. 16%, p = 0.151), or bowel urgency (16% vs. 14%, p = 0.264). There was no difference in the number of patients that answered they will repeat the prostate exam next year (96% vs. 90%, p = 0.162) or in those that would encourage a friend that needs the prostate exam to do it (96% vs. 98%, p = 0.378).
DISCUSSION
Digital rectal exam is an important tool used for diagnosis and clinical staging of prostate cancer. It was used as the only method for the detection of prostate cancer for many years. Even after the introduction of PSA for clinical use in 1985 -1986 evidences suggest that combining PSA and DRE improves the overall rate of prostate cancer detection when compared with either test alone (12-14).
Anticipated pain or discomfort is one of the main barriers to prostate cancer screening (8). In this study, we found that 73% of the patients complained of moderate or higher discomfort for at least one of the domains evaluated during DRE.
Several medical conditions may produce pain or discomfort during DRE including anal fissure, abscess and fistula, prostatitis and prostatic abscess. In the absence of organic disease, pain may result from anal sphincter contraction and palpation of the prostate, seminal vesicles and bladder trigone. All these structures are innervated by afferent branches of the visceral nervous system, which transmit sensations of pain by branches of both the parasympathetic and sympathetic divisions of the autonomic nervous system. Sociodemographic factors -age, race, level of education and income -may alter pain/discomfort perception (7,9,10,15). Patients' beliefs, anxiety and attitudes may also account on patient discomfort (7, 10, 11, 15) . They may feel embarrassed about undressing, worried about cleanliness, and fear discovering a pathological condition. Lack of information about the procedure and lack of empathy and gentleness from the examiner are also perceived as important factors (7, 10, 15) . A sense of vulnerability and defenselessness associated with patient positioning may interfere with physical and psychological distress associated with the examination (11).
Physical and psychological trauma experienced during screening may result in decreased compliance with future screening (9-11). Negative experiences reported by friends may also influence screening compliance (9). In our study, most patients responded they will repeat the prostate exam the following year. They also answered they would encourage a friend that needs the prostate exam to do it, and these responses were not different regardless of the discomfort level experienced during DRE. Even though patients responded positively regarding potential future screening compliance, suggesting that they understand the gravity of regular examinations, intention to undergo screening does not necessarily reflect actual screening compliance.
Reduction in physical stress during DRE is expected to improve patient satisfaction and compliance. Previous information about the procedure, examination in a warm and reserved exam room with a toilet, positioning the patient in the modified lithotomy position which allows direct eye contact of the patient with the examiner, and explaining the findings to the patient during the examination may all help reduce the patients' physical and psychological distress.
In this study, emptying the bladder immediately before DRE resulted in a decrease from 22% to 16% in moderate to unbearable urinary urgency. This result however did not reach statistical significance. Although this may be explained because of the relatively small number of patients in each group, alternative explanations must be considered. The volume of urine in the patients that did not urinate before DRE (control group) was not evaluated. Some patients may have urinated before entering the medical office. Additionally, we did not assess residual urine volu-me in patients that urinated before DRE (intervention group). Finally, urinary urgency may have resulted from touching the prostate and bladder trigone independently of the amount of urine in the bladder. These issues should be specifically addressed in future studies. We would argue however that if our results are confirmed physicians and primary care providers may save time by skipping the pre-DRE void.
Although the questionnaire used in this study was not validated, the scale used in this study is well established and has been extensively used in clinical research for evaluation of pain and discomfort.
Our study shows that patients may feel significant discomfort with DRE even in the absence of organic disease, justifying the fear of pain reported as an important barrier to prostate cancer screening.8 Patients should be informed about the probability of feeling temporary pain or discomfort during prostate exam. Measures to decrease patient distress when screening for prostate cancer should be evaluated.
CONCLUSIONS
Our study challenges the concept that the prostate exam is a painless procedure since less than a third of our patients reported mild or no pain during DRE. Urinary urgency and bowel urgency occur in a smaller percentage of patients. The degree of pain or discomfort does not affect intention to have a prostate exam in the future. Urinating immediately before examination does not significantly reduce the incidence of pain, urinary urgency, or bowel urgency during DRE.
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